This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q87932719
rdf:type
wikibase:Item
schema:description
clinical trial կլինիկական փորձարկում клінічне випробування klinisch onderzoek ensayu clínicu
rdfs:label
BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT) BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)
skos:prefLabel
BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT) BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)
schema:name
BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT) BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)
p:P1476
wds:Q87932719-D20382F1-2A86-435E-9A02-47259B9169E1
wdt:P1476
A Phase 1b Trial of Sequential Combinations of BN-Brachyury, Entinostat, Ado-trastuzuamb Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT)
p:P582
wds:Q87932719-84DBD6D7-9DB3-4E44-97DE-65FE57A4C3C2
wdt:P582
2022-01-01T00:00:00Z
p:P31
wds:Q87932719-B4A57661-A1D0-4CD8-853D-D4889B7DFC87
wdt:P31
wd:Q30612
p:P580
wds:Q87932719-441853B1-EBB3-4A04-997D-93F17A399903
wdt:P580
2020-03-23T00:00:00Z
p:P17
wds:Q87932719-B385FE7A-7F80-41C3-856C-2D098866F21B
wdt:P17
wd:Q30
p:P921
wds:Q87932719-29B27F75-4F1D-4291-97C1-C4262479E6F6
wdt:P921
wd:Q55780068
p:P4844
wds:Q87932719-6CE2C624-CC1E-4F2C-AA80-EBC899D28ABE wds:Q87932719-A2812FF6-B68E-41EF-AC58-F4FB21D25ABC wds:Q87932719-8D8816EB-EA5F-45C8-B95E-1B6EAB745F3B wds:Q87932719-6EA72E46-A67D-482D-B629-C4E40F0DBC4B
wdt:P4844
wd:Q412616 wd:Q6720157 wd:Q1281020 wd:Q3997863
p:P2899
wds:Q87932719-5ECC1B16-DF24-42D7-8C79-33338A2599EC
wdt:P2899
18
p:P859
wds:Q87932719-5D7EE7E1-53B8-4767-AE63-DC909B7AC147
wdt:P859
wd:Q664846
p:P1132
wds:Q87932719-0C5F99C0-2D37-4C22-BA9D-19B3499DF4CE
wdt:P1132
55
p:P8363
wds:Q87932719-23196AB3-74CE-4576-8A15-45695C86D6E9
wdt:P8363
wd:Q78089383
p:P3098
wds:Q87932719-3780B599-9CE6-4C60-85BE-8C30DEFA5D0C
wdt:P3098
NCT04296942
p:P6099
wds:Q87932719-228C9B85-16E3-4ACE-B0AE-EF9B4D1BAF0F
wdt:P6099
wd:Q5452194